ResearcherJohns Hopkins UniversityNo recent work listed
Wei Gong
Matched on ORCID iD 0000-0002-9949-6207; OpenAlex author ID A5101562293. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper
Papers 5
- Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer. Last author DOI 10.7150/ijms.68404↗
- Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13045-021-01203-1↗
- DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway. Co-author DOI 10.7150/ijbs.55636↗
- Estrogen-Related Receptor-α Promotes Pancreatic Cancer Progression by Enhancing the Transcription of PAI1 and Activating the MEK/ERK Signaling Pathway Last author DOI 10.21203/rs.3.rs-33052/v1↗
- ZFX Promotes Proliferation and Metastasis of Pancreatic Cancer Cells via the MAPK Pathway. Co-author DOI 10.1159/000491727↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shilei Liu · 3 shared papers, 2020–2022 · strength 0.40
- Paper Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer. DOI 10.7150/ijms.68404↗
- Paper DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pat… DOI 10.7150/ijbs.55636↗
- Paper Estrogen-Related Receptor-α Promotes Pancreatic Cancer Progression by Enhancing the Transcription of PAI1 and Activatin… DOI 10.21203/rs.3.rs-33052/v1↗
- Lei Zheng · 1 shared paper, 2022 · strength 0.15
- Kenji Fujiwara · 1 shared paper, 2021 · strength 0.14
- Qian Xiao · 1 shared paper, 2021 · strength 0.14
- Xingyi Pan · 1 shared paper, 2021 · strength 0.14
- Lei Zheng · 1 shared paper, 2021 · strength 0.14
- Ziyi Yang · 1 shared paper, 2021 · strength 0.13
- Yingbin Liu · 1 shared paper, 2018 · strength 0.07
- Jun Fei Gu · 1 shared paper, 2018 · strength 0.07
- Fei Zhang · 1 shared paper, 2018 · strength 0.07
- Xiaoling Song · 1 shared paper, 2018 · strength 0.07
- Jianhua Lu · 1 shared paper, 2018 · strength 0.07
- Minghui Zhu · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.